BridgeBio Pharma (BBIO) Times Interest Earned (2018 - 2026)
BridgeBio Pharma's (BBIO) quarterly Times Interest Earned came in at -$8.19 in Q1 2026, down 42.14% year-on-year from -$14.15 in Q1 2025, and up 31.74% quarter-over-quarter from -$11.99 in Q4 2025.
BridgeBio Pharma (BBIO) Times Interest Earned (2018 - 2026) Analysis & Trends
BridgeBio Pharma has disclosed Times Interest Earned across 9 years of filings, most recently posting -$8.19 for Q1 2026.
- Times Interest Earned for Q1 2026 came in at -$8.19, down 42.14% year-over-year; the trailing twelve-month figure through Mar 2026 was -$7.1 (up 12.86% YoY), and the FY2025 annual result was -$9.86, down 51.25% from the prior year.
- Times Interest Earned came in at -$8.19 for Q1 2026 at BridgeBio Pharma, up from -$11.99 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $0.01 in Q1 2024 to a low of -$12.37 in Q3 2025.
- The 5-year median for Times Interest Earned is -$7.65 (2024), against an average of -$7.28.
- Across the five-year window, Times Interest Earned jumped 100.23% in 2024 and sank 39512.98% in 2025, its largest moves.
- BridgeBio Pharma's Times Interest Earned stood at -$6.46 in 2022, then plunged by 35.4% to -$8.75 in 2023, then fell by 19.98% to -$10.5 in 2024, then declined by 14.21% to -$11.99 in 2025, then jumped by 31.74% to -$8.19 in 2026.
- The last three Times Interest Earned figures came in at -$8.19 (Q1 2026), -$11.99 (Q4 2025), and -$12.37 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | BridgeBio Pharma | 12.90 Bn | 11.97 Bn | 184.58 Mn | -8.19 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.19 |
| Dec 31, 2025 | -11.99 |
| Sep 30, 2025 | -12.37 |
| Jun 30, 2025 | -3.57 |
| Mar 31, 2025 | -5.76 |
| Dec 31, 2024 | -10.50 |
| Sep 30, 2024 | -8.31 |
| Jun 30, 2024 | -7.65 |
| Mar 31, 2024 | 0.01 |
| Dec 31, 2023 | -8.75 |
| Sep 30, 2023 | -7.77 |
| Jun 30, 2023 | -7.09 |
| Mar 31, 2023 | -6.27 |
| Dec 31, 2022 | -6.46 |
| Sep 30, 2022 | -6.51 |
| Jun 30, 2022 | -3.95 |
| Mar 31, 2022 | -8.54 |
| Dec 31, 2021 | -10.94 |
| Sep 30, 2021 | -13.51 |
| Jun 30, 2021 | -8.67 |